Startseite>>Signaling Pathways>> Apoptosis>> TNF-α>>Belimumab

Belimumab

Katalog-Nr.GC65031

Belimumab (LymphoStat B) ist ein humaner monoklonaler IgG1Λ-AntikÖrper, der den B-Zell-aktivierenden Faktor (BAFF) hemmt.

Products are for research use only. Not for human use. We do not sell to patients.

Belimumab Chemische Struktur

Cas No.: 356547-88-1

Größe Preis Lagerbestand Menge
5mg
108,00 $
Auf Lager
10mg
180,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Belimumab (LymphoStat B) is a human IgG1Λ monoclonal antibody that inhibits B-cell activating factor (BAFF). Belimumab can be used for systemic lupus erythematosus (SLE) research[1].

[1]. Hannah A Blair, et al. Belimumab: A Review in Systemic Lupus Erythematosus. Drugs. 2018 Mar;78(3):355-366.

Bewertungen

Review for Belimumab

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Belimumab

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.